MEDDDICAL now provides strategic advisory services for MedTech organizations developing real-world evidence (RWE) programs, introducing a structured approach that helps teams establish evidence requirements before evaluating health data providers. The service helps pharmaceutical and MedTech organizations align data partnerships with clinical, commercial, and market access objectives before significant resources are committed.
More information is available at https://medddical.com/
Real-world evidence continues to play a growing role in regulatory submissions, market access, health economics, and commercial decision-making. According to IQVIA, the volume and diversity of available real-world health data have expanded rapidly in recent years, giving life sciences organizations unprecedented access to patient-level insights. As the number of datasets, analytical platforms, and specialist providers continues to grow, the challenge has shifted from finding data to determining which evidence strategy best supports a program's objectives.
MEDDDICAL notes that one of the most expensive decisions in an evidence program often occurs before a dataset is ever licensed. Many organizations begin comparing vendors before clearly defining the business question they need the evidence to answer. Without established requirements, it becomes difficult to determine which combination of claims data, study design, analytical methods, and compliance capabilities best supports the program's objectives, increasing the risk of unnecessary expenditure and evidence that falls short of strategic needs.
"Successful evidence programs begin with a clearly defined question, not a vendor comparison," a MEDDDICAL spokesperson said. "Once the objectives are established, evaluating data partners becomes a strategic exercise focused on identifying the capabilities that best support those goals."
Building on that principle, MEDDDICAL helps MedTech organizations define evidence requirements before evaluating data partners, compliance considerations, and analytical approaches. The company acts as an independent strategic advisor throughout the planning process, helping clients assess which data sources, analytical approaches, and health insurance data partnerships are most appropriate for their specific commercial, clinical, or reimbursement objectives.
About MEDDDICAL
MEDDDICAL advisors support pharmaceutical and MedTech organizations in health market intelligence and real-world evidence. The multidisciplinary team combines expertise in health economics, statistics, and data science to help clients evaluate evidence strategies and connect with qualified health insurance data partners across Europe and globally.
Additional information is available at https://medddical.com/